Search Results
451 items found for "Cyclin D"
- Stretch regulates alveologenesis and homeostasis via mesenchymal Gαq/11-mediated TGFβ2 activation
Mice with constitutive Gαq/11 gene deletion exhibited abnormal alveolar development, with suppressed reduced TGFβ2 and elastin deposition. Cyclical mechanical stretch-induced TGFβ activation required Gαq/11 signalling and serine protease activity These data highlight a previously undescribed mechanism of cyclical stretch-induced Gαq/11-dependent Tags Alveologenesis , Cyclical mechanical stretch , GPCR , Gαq/11 , Lung development , TGFβ .
- Ep 66 with Dr. Antony A. Boucard Jr
Dr. GPCR Podcast << Back to podcast list Dr. Antony A. Boucard Jr About Dr. Antony A. Boucard Jr. Dr. Richard Leduc and Dr. Dr. His lab highlighted the importance of splicing events in biasing latrophilins’ regulation of cyclic AMP
- Ep 57 with Dr. Peter Robert Banks
Dr. GPCR Podcast << Back to podcast list Dr. Peter Robert Banks About Dr. Peter Robert Banks Peter Banks is currently the Scientific Director at BioTek Instruments , now a part Before joining BioTek in 2008, Banks was employed by PerkinElmer for a decade. These roles included management of PerkinElmer’s BioPharma R&D program and Chair of the company’s Scientific Dr. Peter Robert Banks on the web LinkedIn Dr.
- Ep 17 with Dr. Yamina Berchiche
Dr. GPCR Podcast << Back to podcast list Dr. During the past 2 decades, my research mainly focused on chemokine receptor structure/function relationships each experience, which ultimately led me to found Dr. Martha Summer and Dr. Alexander Hauser , and Luise Wagner . Dr. Yamina Berchiche on the web D r.
- Ep 141 with Dr Tobi Langenhan
Dr. GPCR Podcast << Back to podcast list Dr. Tobi Langenhan About Dr. . med. degree in neuroanatomy. For my doctoral studies, I joined the lab of Dr Andreas Russ at the Department of Biochemistry and first I work with invertebrate animal models (mainly D. melanogaster) and in vitro techniques to pick apart Dr. Tobi Langenhan on the web Langenhan Lab ORCID LinkedIn University of Leipzig Dr.
- Ep 84 with Rosie Dawaliby
Dr. GPCR Podcast << Back to podcast list Dr. Rosie Dawaliby About Dr. Rosie Dawaliby "I’m an expert in early-stage drug discovery, targeting membrane proteins, especially I have 10 years of experience in the development and management of R&D projects and teams in the field of the lipidic environment on their structure and function during my post-doctoral work (2010-2015). Dr. Rosie Dawaliby on the web LinkedIn Dr.
- Ep 105 with Annabelle Milner
Dr. Back to podcast list Annabelle Milner About Annabelle Milner Annabelle completed her undergraduate degree in Sydney, investigating the effects of dietary carbohydrates on metabolic health with Dr. In particular, she is looking at L- and D-lactate-activated HCAR1 signaling. Annabelle Milner on the web Linkedin Researchgate Pubmed Dr.
- Ep 153 with Dr Jacek Mokrosiński
Dr. GPCR Podcast << Back to podcast list Exploring Career Paths in GPCR Research with Dr. Jacek Mokrosiński About Dr. He works in a multidisciplinary Chemical Biology team based at the recently established US R&D hub in Dr. Jacek Mokrosiński on the web ORCID ResearchGate LinkedIn Twitter Dr. , and the importance of a multidisciplinary approach in drug development.
- Ep 151 with Dr GPCR Board
Dr. GPCR Podcast << Back to podcast list Dr. GPCR Board About Dr. Yamina Berchiche "Dr. Yamina A. Dr. Dr. My experience in basic research at several universities worldwide and early R&D at Novo Nordisk A/S allowed Dr. Maria Waldhoer on the web LinkedIn T witter Pubmed Dr. GPCR About Dr. JoAnn Trejo "Dr.
- Ep 95 with Chris Langmead
Dr. GPCR Podcast << Back to podcast list Chris Langmead Chris Langmead is Professor, Deputy Director, and health disorders. He also directs a collaborative neuroscience R&D program with Servier (France) and is the co-founder He is an acknowledged expert in drug discovery, particularly in the field of psychiatry, where he has
- Structural Basis for the Recognition of GPRC5D by Talquetamab, a Bispecific Antibody for Multiple Myeloma
for the Recognition of GPRC5D by Talquetamab, a Bispecific Antibody for Multiple Myeloma Published date Despite advances in the treatment, many patients experience disease relapse or become refractory to treatment G-protein-coupled receptor class C group 5 member D (GPRC5D), an orphan GPCR predominantly expressed Talquetamab, a Food and Drug Administration-approved T-cell-directing bispecific antibody developed for A single talquetamab Fab interacts with the GPRC5D dimer with its orientation toward the dimer interface
- Minireview: functional roles of tissue kallikrein, kinins, and kallikrein-related peptidases in lung cancer
functional roles of tissue kallikrein, kinins, and kallikrein-related peptidases in lung cancer Published date July 3, 2023 Abstract "Despite campaigns and improvements in detection and treatment, lung cancer continues Since lung cancer is often diagnosed in advanced stages, our efforts should focus on early diagnosis, Authors Adriana Stuardo-Parada , Rodrigo López-Muñoz , Franz Villarroel-Espindola , Carlos D Figueroa GPCR Create an account and get our contributors articles in your inbox Subscribe to the Dr.
- Session II | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Avila Zozaya Abstract Only available for AGPCR 24 Workshop Attendees Authors & Affiliations "Serafin D. Van Meir "Dr. Erwin Van Meir is a professor in the UAB Department of Neurosurgery. Dr. Our results demonstrate that specific N-glycan residues in different domains of the extracellular NTF During my PhD training, I worked in the laboratory of Dr.
- Trademark Policy | Dr. GPCR Ecosystem
GPCR, Ecosystem.DrGPCR.com, DrGPCR.com. If Dr. GPCR approves your request to use any Dr. Dr. Report inappropriate use of a D. GPCR trademark. Buttons And Badges The Dr. GPCR development of Dr. GPCR Buttons. By using a Dr. GPCR button, Publishers give Dr. Using Dr. GPCR logo The Dr.
- GPR68-ATF4 signaling is a novel prosurvival pathway in glioblastoma activated by acidic extracellular microenvironment
novel prosurvival pathway in glioblastoma activated by acidic extracellular microenvironment Published date Despite decades of research, the survival rates for GBM remain effectively stagnant. To determine GPR68 inhibition's mechanism of cell death we use DAVID pathway analysis of RNAseq. H Williams , Leif R Neitzel , Jessica Cornell , Samantha Rea , Ian Mills , Maya S Silver , Jovanni D GPCR Create an account and get our contributors articles in your inbox Subscribe to the Dr.
- Classified News | Dr. GPCR Ecosystem
Get the GPCR's news in your inbox Contributor Articles Dr. GPCR articles Articles from Ecosystem Contributors April 2, 2024 GPCRs are not simple on-off switches: deep dive into GPCR-ligand interactions Read More April 16, 2024 From DNA day to GPCR genomics Read More GPCR Route 66+ project Read More October 1, 2022 GPCRs: Signal Transduction Read More GPCR Binders, Drugs Recorded Courses Exclusive access to early bird special Access to previous events recordings Become Dr
- C-Principles2 (List) | Dr. GPCR Ecosystem
Principles of Pharmacology in Drug Discovery II Advanced Methods for the Optimization of Candidate Selection Dr. be exploited for new drug discovery. November 7th: Drug Disposition in Physiological Tissues as a Therapeutic Variable. Pharmacology in Drug Discovery and Development (3rd ed.)
- Full Agenda for Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
/independent activation mechanism in AGPCRs Signe Mathiasen · Demet Araç · Andrew Dates · Frank Kwarcinski and Its Impact on GAIN Domain Autoproteolysis Andrew Dates Heterogeneity of Tethered Agonist Signaling Discovery Fabian Pohl Structural Determinants Of GAIN Domain Autoproteolysis And Cleavage Resistance Douglas Tilley ADGRF5-mediated regulation of cardiac health and disease Abhishek Kumar Singh Adgrg6/ discovery
- C-Principles1 (List) | Dr. GPCR Ecosystem
Principles of Pharmacology in Drug Discovery I Techniques for Effective Lead Optimization of Candidate Molecules Dr. a GPCR Target Program aimed at the discovery of new Drugs. Modules: October 3rd: GPCR Project Initiation and Design for Discovery of New Molecules. Registration over Subscribe to Dr.
- Home | Dr. GPCR Ecosystem
Home: About Welcome to Dr. GPCR Ecosystem We dream of a world where the vast majority of us lead a fulfilling and healthy life. Home: Contact Become a Premium Member Individuals Explore all benefits for individuals Organizations Discover
- Dr. GPCR Ecosystem
Home: About Welcome to Dr. GPCR Ecosystem We dream of a world where the vast majority of us lead a fulfilling and healthy life. the organizations benefits What did you miss from the ecosystem? GPCR Courses Adhesion GPCR Workshop 2024 CINVESTAV , Mexico City, Mexico October 23-25, 2024 Register Dr GPCR Weekly News Dr. GPCR Articles Dr. GPCR Monthly Newsletter Dr. GPCR Podcast
- University | Dr. GPCR Ecosystem
Dr. GPCR University The Dr. Get started - 5 days free trial - Sign up for free! Dr. GPCR Courses Details Dr. GPCR Symposia Details Dr. GPCR Summit Details Dr. GPCR Virtual Cafe Details Our Vision Closing the gap ( between academia and industry ) and accelerating drug discovery.
- Ep 67 with Dr. Graham Ladds
Dr. GPCR Podcast << Back to podcast list Dr. Graham Ladds About Dr. He continued to work at Warwick as a post-doc studying pro-hormone convertases before securing a 5-year progressed through the ranks at Warwick to become an Associate Professor before leaving in 2015 to join the Department Dr. Graham Ladds on the web Twitter ResearchGate LinkedIn Google Scholar PubMed Dr.
- Ep 109 with Dr. Katarina Nemec
Dr. GPCR Podcast << Back to podcast list Dr. Katarina Nemec About Dr. I aim to discover new therapeutic approaches, and druggable molecules or refine canonical drug targets to create drugs with fewer adverse effects. During my PhD studies in Martin Lohse lab at the Max Delbrueck Center in Berlin, I consolidated my knowledge I want to combine experimental approaches with data-driven discovery and adopt data science methodology
- Ep 100 with Dr Caron Tribute Part 1
Dr. GPCR Podcast << Back to podcast list Dr. Caron Tribute Part 1 About Marc Caron Dr. Duke Professor until his death. such as schizophrenia, Parkinson's disease, attention-deficit hyperactivity disorder, mood disorders Jeffrey Benovic (1985) Dr. Michel Bouvier (1985) Dr. Kathleen Caron - Co-host- (1970) Dr. Richard Cerione (1985) Dr. Brian Kolbilka (1987) Dr. Frederik Leeb-Lundberg (1984) Dr.
- Ep 122 with Dr. Nicolas Gilles
Dr. GPCR Podcast << Back to podcast list Dr. Nicolas Gilles About Dr. Nicolas Gilles "Dr. When the pharmacological properties of these new ligands are deemed exceptional, a lead optimization is realized and its therapeutic development initiates through a dedicated start-up." Dr. Nicolas Gilles on the web Google Scholar LinkedIn Dr.
- Ep 49 with Dr. Sudha Shenoy
Dr. GPCR Podcast << Back to podcast list Dr. Sudha Shenoy About Dr. Sudha Shenoy Dr. Lefkowitz (Nobel Laureate, 2012) at Duke University. Dr. Dr. Sudha Shenoy on the web Duke University Personal Reflections and Words of Wisdom: Story From Dr. Sudha Shenoy LinkedIn Pubmed Dr.
- Dinner 1
About Program Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to schedule Dinner 1 Date & Time Thursday, November 2nd / 8:00 PM Previous Event Next Event Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec 22nd GPCR Retreat Sponsored by